Collegium Pharmaceutical Ratios (2016-2025) | COLL

Ratios Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 92.89%85.88%82.92%83.79%87.37%89.86%32.38%35.89%34.44%59.52%34.02%35.16%35.90%33.85%50.96%61.96%60.87%58.07%63.38%60.57%58.49%-4.87%57.90%42.38%46.33%38.41%53.47%54.47%58.75%63.19%63.11%62.51%60.76%54.02%54.75%57.65%61.70%
EBT Margin 53,304.35%-6,481.86%-2,113.66%-1,062.52%-593.29%-303.02%-161.23%-29.26%-17.88%-23.52%12.37%-13.02%-6.28%-8.38%-2.97%0.59%10.64%14.61%9.52%17.64%13.25%11.46%-142.08%-18.92%-5.38%1.13%-6.01%-12.13%13.13%21.05%31.19%25.27%20.03%9.78%9.49%1.76%9.06%20.75%
EBIT Margin 53,204.35%-6,480.88%-2,116.58%-1,067.03%-597.13%-306.83%-162.90%-20.72%-9.98%-15.94%14.98%-13.41%-6.67%-8.74%-3.20%6.61%21.20%24.79%19.66%24.16%19.78%17.95%-124.71%-11.96%8.99%16.11%9.07%17.01%26.29%32.93%41.20%34.14%32.68%21.87%20.95%12.20%18.67%29.66%
EBITDA Margin 53,204.35%-6,480.88%-2,116.58%-1,067.03%-597.13%-306.83%-162.90%-20.72%-9.98%-15.94%14.98%-13.41%-6.67%-8.74%-3.20%6.61%21.20%24.79%19.66%24.16%19.78%17.95%-124.71%-11.96%8.99%16.11%9.07%17.01%26.29%32.93%41.20%34.14%32.68%21.87%20.95%12.20%18.67%29.66%
Operating Margin 53,204.35%-6,480.88%-2,116.58%-1,067.03%-597.13%-306.83%-162.90%-20.72%-9.98%-15.94%14.98%-13.41%-6.67%-8.74%-3.20%6.61%21.20%24.79%19.66%24.16%19.78%17.95%-124.71%-11.96%8.99%16.11%9.07%17.01%26.29%32.93%41.20%34.14%32.68%21.87%20.95%12.20%18.67%29.66%
Net Margin 53,304.35%-6,481.86%-2,113.66%-1,062.52%-593.29%-303.02%-161.23%-29.26%-17.88%-23.52%12.37%-13.02%-6.28%-8.38%-2.97%0.59%10.32%14.25%9.12%19.18%89.23%10.21%-91.49%-15.60%-4.20%0.36%-5.55%-12.04%9.60%15.09%21.33%19.12%13.50%5.86%6.89%1.36%6.37%15.05%
FCF Margin 45,295.65%-4,785.54%-1,813.35%-1,091.94%-503.26%-294.88%-124.77%45.97%75.24%55.74%55.18%-15.96%18.33%6.47%19.90%-9.81%55.12%40.13%27.66%22.96%34.74%21.53%130.41%-30.36%32.37%33.58%50.44%18.99%73.53%54.10%48.87%42.35%46.21%-5.80%46.21%30.72%38.50%37.38%
Efficiency
Inventory Average 1.40M1.45M1.41M1.51M1.46M1.61M4.86M8.22M8.89M8.52M8.28M9.35M9.36M9.20M12.80M17.39M17.98M16.38M15.56M17.55M18.48M17.38M48.77M78.96M71.21M55.58M39.70M29.46M30.08M33.23M31.80M29.57M32.95M36.80M36.39M37.68M38.10M
Assets Average 128.03M109.22M130.37M150.93M132.18M123.59M129.12M415.92M684.80M659.92M468.88M292.80M297.97M302.78M305.14M470.55M640.83M645.36M643.84M644.95M679.90M727.77M716.94M969.11M1,245.86M1,223.26M1,187.54M1,194.21M1,214.11M1,195.74M1,160.44M1,128.78M1,083.82M1,344.27M1,649.37M1,647.49M1,612.01M1,599.98M
Equity Average 110.20M86.49M104.62M124.64M104.94M95.89M100.17M97.45M86.75M76.73M81.18M88.97M86.09M85.04M85.84M114.25M148.41M164.23M179.36M178.03M211.55M252.08M227.01M199.50M196.84M197.40M196.02M187.29M190.27M189.84M187.15M208.80M219.38M225.43M231.56M231.64M233.32M253.51M
Invested Capital 124.40M101.32M76.99M137.57M116.92M97.90M98.42M105.56M221.88M197.51M187.11M93.23M88.81M87.74M87.13M91.27M341.06M343.27M347.69M348.53M320.04M396.82M394.84M346.68M846.08M822.61M797.19M769.84M729.73M704.97M362.21M378.76M405.50M399.92M298.86M293.43M299.02M296.79M339.39M
Asset Utilization Ratio 0.010.030.060.090.160.200.220.330.600.990.980.980.970.630.470.480.480.500.480.450.390.280.250.300.390.440.440.460.490.500.530.450.380.400.440.47
Leverage & Solvency
Interest Coverage Ratio -532.04-0.01M0.00M-2.32-1.18-1.914.58-42.70-21.22-27.96-11.251.052.002.431.943.703.032.77-7.17-1.720.631.070.571.151.632.173.202.853.051.891.681.041.722.85
Debt to Equity 0.050.060.060.030.030.030.020.011.571.531.790.130.130.130.140.131.371.160.980.850.860.530.490.543.203.072.962.872.992.462.512.071.621.462.692.692.562.522.07
Debt Ratio 0.050.050.050.030.020.020.020.010.200.190.200.040.040.040.040.040.300.280.260.240.230.190.160.160.500.490.490.480.440.410.380.350.320.300.390.370.370.370.35
Equity Ratio 0.890.820.750.830.820.770.780.770.130.120.110.310.290.280.280.290.220.240.270.290.260.350.340.290.160.160.160.170.150.170.150.170.200.210.140.140.140.150.17
Times Interest Earned -532.04-0.01M0.00M-2.32-1.18-1.914.58-42.70-21.22-27.96-11.251.052.002.431.943.703.032.77-7.17-1.720.631.070.571.151.632.173.202.853.051.891.681.041.722.85
Valuation
Enterprise Value -134.73M-110.75M-91.03M-153.22M-129.56M-111.21M-107.61M-118.70M-128.25M-133.75M-139.79M-146.63M-134.91M-148.71M-153.84M-170.02M-116.18M-145.68M-165.42M-174.12M-182.79M-202.77M-193.24M-186.43M-106.70M-122.72M-134.13M-173.69M-269.48M-325.47M-304.56M-310.55M-318.05M-271.63M-119.96M-162.76M-197.77M-222.15M-285.86M
Return Ratios
Return on Sales 533.04%-64.82%-21.14%-10.63%-5.93%-3.03%-1.61%-0.29%-0.18%-0.24%0.12%-0.13%-0.06%-0.08%-0.03%0.00%0.10%0.14%0.09%0.18%0.88%0.10%-0.91%-0.16%-0.04%0.00%-0.06%-0.12%0.10%0.15%0.21%0.19%0.13%0.06%0.07%0.01%0.06%0.15%
Return on Capital Employed -0.80%-0.95%-0.88%-0.77%-0.40%-0.12%-0.13%-0.07%-0.17%-0.15%-0.10%-0.23%-0.04%0.03%0.10%0.14%0.17%0.16%0.15%0.04%-0.02%-0.02%-0.02%0.04%0.09%0.12%0.16%0.24%0.28%0.33%0.22%0.15%0.12%0.11%0.14%
Return on Invested Capital 0.00%0.11%0.16%0.21%0.47%0.41%-1.01%0.03%-0.02%-0.01%0.04%0.09%0.24%0.09%0.29%0.35%0.36%0.38%0.40%0.32%0.30%0.36%
Return on Assets -0.60%-0.67%-0.74%-0.69%-0.58%-0.17%-0.09%-0.10%-0.08%-0.10%-0.07%-0.04%-0.07%-0.03%0.00%0.03%0.04%0.07%0.16%0.14%0.10%0.04%-0.03%-0.04%-0.02%-0.02%-0.01%0.01%0.04%0.08%0.09%0.07%0.04%0.03%0.02%0.04%
Return on Equity -0.75%-0.82%-0.94%-0.89%-0.75%-0.72%-0.72%-0.86%-0.48%-0.34%-0.25%-0.13%-0.26%-0.11%0.00%0.11%0.15%0.24%0.50%0.41%0.32%0.21%-0.18%-0.22%-0.13%-0.16%-0.06%0.05%0.26%0.45%0.46%0.39%0.30%0.19%0.16%0.23%